(Q40100231)

17 September 2017

title

Disease control intervals in high-risk neuroblastoma (English)

1 reference

17 September 2017

2

Wayne L Furman

1 reference

17 September 2017

Victor M Santana

1

1 reference

17 September 2017

Lisa M McGregor

series ordinal

3

1 reference

17 September 2017

Catherine A Billups

series ordinal

4

1 reference

17 September 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

17 September 2017

1 reference

17 September 2017

volume

112

1 reference

17 September 2017

issue

12

1 reference

17 September 2017

page(s)

2796-2801

1 reference

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23507

Advances in the diagnosis and treatment of neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23507

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.23507

1 reference

7 January 2021

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23507

7 January 2021

Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23507

7 January 2021

Long-term results and risk profiles of patients in five consecutive trials (1979-1997) with stage 4 neuroblastoma over 1 year of age.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23507

7 January 2021

Survival after relapse in children with solid tumors: a follow-up study from the Italian off-therapy registry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23507

7 January 2021

Factors influencing survival in children with recurrent neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23507

7 January 2021

Combined use of erythropoietin and granulocyte colony-stimulating factor does not decrease blood transfusion requirements during induction therapy for high-risk neuroblastoma: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23507

7 January 2021

Improved response in high-risk neuroblastoma with protracted topotecan administration using a pharmacokinetically guided dosing approach

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23507

7 January 2021

The impact of early resection of primary neuroblastoma on the survival of children older than 1 year of age with stage 4 disease: the St. Jude Children's Research Hospital Experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23507

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23507

7 January 2021

Chronic neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23507

7 January 2021

Sorafenib for the treatment of advanced renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23507

7 January 2021

Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23507

7 January 2021

End points and United States Food and Drug Administration approval of oncology drugs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23507

7 January 2021

Imaging proliferation in vivo with [F-18]FLT and positron emission tomography.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23507

7 January 2021

[18F]FLT-PET in oncology: current status and opportunities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23507

7 January 2021

Identifiers

DOI

10.1002/CNCR.23507

1 reference

17 September 2017

1 reference